LLY · 10-Q · 2026Q2 · Full report
Outstanding Indebtedness and Credit Facilities
ELI LILLY & Co · 2026-08-05 · Importance 79 · Surprise 66 · In source text
Lilly issued $9.0 billion of long-term debt in May 2026 for general corporate purposes, including repaying commercial paper and funding part of the Centessa and Kelonia acquisition consideration. Total debt was $54.9 billion at June 30, 2026, up $12.4 billion from $42.5 billion at December 31, 2025. Lilly had $10.1 billion of unused committed bank credit facilities, including $10.0 billion available to support its commercial paper program. Existing commercial paper markets and other sources were considered adequate for short-term borrowing needs.
Key facts
- In May 2026, the company issued long-term debt totaling $9.0 billion and used net cash proceeds for general corporate purposes, including repayment of outstanding commercial paper and funding a portion of upfront cash consideration and related fees and expenses payable in connection with acquisitions of Centessa and Kelonia. source
- Total debt as of June 30, 2026: $54.9 billion, an increase of $12.4 billion compared with $42.5 billion as of December 31, 2025. source
- As of June 30, 2026, the company had $10.1 billion of unused committed bank credit facilities, $10.0 billion of which is available to support the commercial paper program. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | realized | -8.7% | Total debt as of June 30, 2026: $54.9 billion, an increase of $12.4 billion compared with $42.5 billion as of December 31, 2025. |